nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Assessment of the Impact of Informative Dropout and Nonresponse in Measuring Health-Related Quality of Life Using the EuroQol (EQ-5D) Descriptive System
|
Ratcliffe, Julie |
|
2005 |
8 |
1 |
p. 53-58 6 p. |
artikel |
2 |
An Evaluation of Managing and Educating Patients on the Risk of Glucocorticoid-Induced Osteoporosis
|
McDonough, Randy P. |
|
2005 |
8 |
1 |
p. 24-31 8 p. |
artikel |
3 |
Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations?
|
O'Sullivan, Amy K. |
|
2005 |
8 |
1 |
p. 67-79 13 p. |
artikel |
4 |
Development and Initial Validation of an Instrument to Measure Physician–Pharmacist Collaboration from the Physician Perspective
|
Zillich, Alan J. |
|
2005 |
8 |
1 |
p. 59-66 8 p. |
artikel |
5 |
Effect of Outpatient Treatment of Febrile Neutropenia on the Risk Threshold for the Use of CSF in Patients with Cancer Treated with Chemotherapy
|
Cosler, Leon E. |
|
2005 |
8 |
1 |
p. 47-52 6 p. |
artikel |
6 |
Growth and Quality of the Cost–Utility Literature, 1976–2001
|
Neumann, Peter J. |
|
2005 |
8 |
1 |
p. 3-9 7 p. |
artikel |
7 |
Needs-Based Health-Related Quality of Life Measurement: New Wine in Old Bottles?
|
|
|
2005 |
8 |
1 |
p. 82-83 2 p. |
artikel |
8 |
Needs-Based Quality of Life (QoL): More Clarity than Claret!
|
|
|
2005 |
8 |
1 |
p. 84-85 2 p. |
artikel |
9 |
Probabilistic Analysis of Cost-Effectiveness Models: Statistical Representation of Parameter Uncertainty
|
Briggs, Andrew |
|
2005 |
8 |
1 |
p. 1-2 2 p. |
artikel |
10 |
Probabilistic Markov Model to Assess the Cost-Effectiveness of Bronchodilator Therapy in COPD Patients in Different Countries
|
Oostenbrink, Jan B. |
|
2005 |
8 |
1 |
p. 32-46 15 p. |
artikel |
11 |
Some Considerations for the Interpretation of Health-Related Quality of Life Data
|
|
|
2005 |
8 |
1 |
p. 80-81 2 p. |
artikel |
12 |
Thresholds in Cost-Effectiveness Analysis—More of the Story
|
|
|
2005 |
8 |
1 |
p. 86-87 2 p. |
artikel |
13 |
Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability
|
Barbieri, Marco |
|
2005 |
8 |
1 |
p. 10-23 14 p. |
artikel |